Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Endothelial cell–specific LAT1 ablation normalizes tumor vasculature
Jun-ichi Suehiro, Toru Kimura, Toshiyuki Fukutomi, Hisamichi Naito, Yasuharu Kanki, Youichiro Wada, Yoshiaki Kubota, Nobuyuki Takakura, Hiroyuki Sakurai
Jun-ichi Suehiro, Toru Kimura, Toshiyuki Fukutomi, Hisamichi Naito, Yasuharu Kanki, Youichiro Wada, Yoshiaki Kubota, Nobuyuki Takakura, Hiroyuki Sakurai
View: Text | PDF
Research Article Angiogenesis Vascular biology

Endothelial cell–specific LAT1 ablation normalizes tumor vasculature

  • Text
  • PDF
Abstract

Some endothelial cells in the tumor vasculature express a system L amino acid transporter, LAT1. To elucidate the role of LAT1 in tumor-related endothelial cells, tumor cells were injected into endothelial cell–specific LAT1 conditional knockout mice (Slc7a5flox/flox; Cdh5-Cre-ERT2), and we found that the shape of the tumor vasculature was normalized and the size and numbers of lung metastasis was reduced. TNF-α–induced expression of VCAM1 and E-selectin at the surface of HUVEC, both of which are responsible for enhanced monocyte attachment and premetastatic niche formation, was reduced in the presence of LAT1 inhibitor, nanvuranlat. Deprivation of tryptophan, a LAT1 substrate, mimicked LAT1 inhibition, which led to activation of MEK1/2-ERK1/2 pathway and subsequent cystathionine γ lyase (CTH) induction. Increased production of hydrogen sulfide (H2S) by CTH was at least partially responsible for tumor vascular normalization, leading to decreased leakiness and enhanced delivery of chemotherapeutic agents to the tumor.

Authors

Jun-ichi Suehiro, Toru Kimura, Toshiyuki Fukutomi, Hisamichi Naito, Yasuharu Kanki, Youichiro Wada, Yoshiaki Kubota, Nobuyuki Takakura, Hiroyuki Sakurai

×

Figure 5

Slc7a5iEC–KO mice promoted tumor vessel normalization and mesenchymal cell migration via Cth induction.

Options: View larger image (or click on image) Download as PowerPoint
Slc7a5iEC–KO mice promoted tumor vessel normalization and mesenchymal ce...
(A) Aortic ring assay in control or Slc7a5iEC–KO mice. Area of phalloidin-positive cells (mean ± SEM) was calculated from 6 randomly selected images derived from each mouse and normalized to that of control mice (the mean of the control mice was calculated as 100%). (B) Matrigel plug assay in control, Slc7a5iEC–KO or GYY4137 treated C57BL/6J mice (mean ± SEM, control; n = 12, Slc7a5iEC–KO mice; n = 9, GYY4137-treated mice; n = 6). Nuclei were counterstained with DAPI (blue). (C) Immunofluorescent analysis of PECAM1 and α-SMA–positive cell localization in Ex-3LLC tumor in Ad-control, Ad-miR-Cth, or Ad-miR-Cth + Ad-CTH infected mice at day 16. Data indicated mean ± SEM (control + Ad-control; n = 12, Slc7a5iEC–KO +Ad-control; n = 10, Slc7a5iEC–KO +Ad-miR-Cth; n = 10, Slc7a5iEC–KO + Ad-miR-Cth and Ad-CTH; n = 10). (D) Immunofluorescent analysis of PECAM1 and α-SMA-positive cell localization in B16F10 tumor at day 15 in Ad-control, Ad-miR-Cth, Ad-miR-Cth + Ad-CTH infected mice. Data indicated mean ± SEM (control + Ad-control; n = 10, Slc7a5iEC–KO +Ad-control; n = 13, Slc7a5iEC–KO +Ad-miR-Cth; n = 8, Slc7a5iEC–KO +Ad-miR-Cth and Ad-CTH; n = 10). (A) P values were determined by 2-tailed, unpaired t test. (B–D) P values were determined by 1-way ANOVA with Holm-Šídák’s multiple comparisons test compared to control. *P < 0.05. Scale bars: 200 μm (A); 100 μm (B–D).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts